(Q43587138)

24 November 2017

title

Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy (English)

1 reference

24 November 2017

1 reference

1 reference

Sun X

1

1 reference

24 November 2017

Kanwar JR

2

1 reference

24 November 2017

Leung E

3

1 reference

24 November 2017

Lehnert K

4

1 reference

24 November 2017

Wang D

5

1 reference

24 November 2017

Krissansen GW

6

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

8

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

638-645

1 reference

The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

The Hsp90 complex--a super-chaperone machine as a novel drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Evaluation of the concentric-circles method for estimating capillary-tissue diffusion distances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

Oxygen sensing and molecular adaptation to hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

The VHL tumour-suppressor gene paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

Immunomodulatory actions of xanthenone anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301388

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301388

1 reference

Dimensions Publication ID

24 November 2017

1027721772

0 references

1 reference